Epigenetics company Base Genomics has launched with a team of leading scientists and clinicians to set a new gold standard in DNA methylation detection.

Mission Bio has extended capabilities for its automated, cloud-based tool for designing targeted single-cell DNA custom panels, now with applications across mouse genomes and CRISPR editing.

Miltenyi Biotec has announced the UltraMicroscope Blaze, the world’s first fully automated light sheet microscope.

Researchers are using chips from Dolomite Microfluidics to reliably and consistently produce monodisperse particles for targeted delivery of small interfering RNA (siRNA) therapeutics.

VAXIMM has announced that the safety run-in results from the trial are being presented as an oral presentation at the 2020 American Society of Clinical Oncology (ASCO) Virtual Meeting.

Horizon Discovery has added two new sample formats to its cell-based OncoSpan reference standards for use in the development and validation of workflows for cancer diagnostic assays.

Researchers at BellBrook Labs have developed a high throughput screening (HTS) assay to discover small molecule modulators for the immunosuppressive ectonucleotidase, CD73.

Oxford Gene Technology has announced the addition of accurate detection capabilities for translocations and difficult-to-sequence partial tandem duplications (PTDs) in its myPanel™ customizable SureSeq™ NGS panels.

The new service from GenScript aims to overcome the challenges of manufacturing difficult neoantigen peptides critical to personalized cancer vaccine and T-cell therapy generation.

Vaccitech Limited and the University of Oxford have announced initial efficacy and safety data for ADVANCE, a Phase 2a study testing VTP-800, an immunotherapeutic product candidate in patients with metastatic castration resistant prostate cancer (mCRPC).